CCND1 and non-small cell lung carcinoma: Collectively, these data demonstrate that SMARCA4 deficiency is associated with reduced cyclin D1 expression and susceptibility to CDK4/6 inhibition in NSCLC, which is in line with our findings in SCCOHT.